Transmyocardial laser revascularisation
Medical Services Advisory Committee
Record ID 31999009750
This report assesses transmyocardial laser revascularisation (TMR), which is a therapeutic procedure for refractory angina.
Authors' recommendations: MSAC found there is insufficient evidence to conclude that the clinical benefits of TMR outweigh the potential risks as: the procedure is associated with 3-5 per cent peri-operative mortality; and there is uncertainty in symptom relief beyond 12 months. In addition, the cost effectiveness ratios are considered unfavourable. MSAC therefore recommends that public funding for TMR should not be supported at this time.
Authors' methods: Systematic review
Project Status: Completed
URL for project: http://www.health.gov.au/haf/msac
Year Published: 1999
English language abstract: An English language summary is available
Publication Type: Not Assigned
- Angina Pectoris
- Costs and Cost Analysis
- Laser Therapy
- Myocardial Revascularization
Organisation Name: Medical Services Advisory Committee
Contact Address: MSAC (MDP 107), GPO Box 9848, Canberra, ACT 2601, Australia. Tel: +61 2 6289 6811; Fax: +61 2 6289 8799.
Contact Name: email@example.com
Contact Email: firstname.lastname@example.org
Copyright: Medical Services Advisory Committee
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.